Using hierarchical cluster analysis, we analyzed insulin secretion, clearance and resistance in a cohort of 953 participants from the PREVADIAB2, previously enrolled in PREVADIAB1 without diabetes. The gene discussed is INS; the disease is diabetes mellitus.